bcr_patient_uuid	patient_ID	bcr_drug_barcode	bcr_drug_uuid	form_completion_date	pharmaceutical_therapy_drug_name	clinical_trial_drug_classification	pharmaceutical_therapy_type	days_to_drug_start	pharmaceutical_tx_ongoing_indicator	days_to_drug_end	treatment_best_response	days_to_stem_cell_transplantation	pharm_regimen	pharm_regimen_other	drug_cycles	pharma_type_other	drug_units	drug_tota_dose_units	drug_dose	regimen_number	drug_route	stem_cell_transplantation	stem_cell_transplantation_type	therapy_regimen	therapy_regimen_other	drug_total_dose	therapy_on_clinical_trial
1	f9204a59-6877-4d06-a20e-fd7ab0859ed5	TCGA.AF.2687	TCGA-AF-2687-D7471	3041c9c2-446a-4fd8-a6b7-b4ea72dda4fd	2011-2-9	XELODA	NA	CHEMOTHERAPY	55	FALSE	97	NA	NA	NA	NA	NA	NA	MG	MG	1500	1	ORAL	NA	NA	ADJUVANT	NA	NA	NA
2	f9204a59-6877-4d06-a20e-fd7ab0859ed5	TCGA.AF.2687	TCGA-AF-2687-D7476	0d0a7050-6694-40d7-8087-f5ea54967092	2011-2-9	5 FU	NA	CHEMOTHERAPY	133	FALSE	261	NA	NA	NA	NA	9	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	34193	NA
3	f9204a59-6877-4d06-a20e-fd7ab0859ed5	TCGA.AF.2687	TCGA-AF-2687-D7474	b1351850-ce3f-4280-8c28-f967e6a594a3	2011-2-9	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	133	FALSE	259	NA	NA	NA	NA	9	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	5750	NA
4	f9204a59-6877-4d06-a20e-fd7ab0859ed5	TCGA.AF.2687	TCGA-AF-2687-D7473	66493de1-960a-4d78-abdb-ad820db8bfc4	2011-2-9	OXALIPLATIN	NA	CHEMOTHERAPY	133	FALSE	259	NA	NA	NA	NA	9	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	1211	NA
5	f9204a59-6877-4d06-a20e-fd7ab0859ed5	TCGA.AF.2687	TCGA-AF-2687-D7475	e024567d-988f-4c5f-b624-b18ee2d0bc40	2011-2-9	5 FU	NA	CHEMOTHERAPY	133	FALSE	259	NA	NA	NA	NA	9	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	5699	NA
6	335d0351-3740-4847-9ff4-be2f078c70f7	TCGA.AF.2689	TCGA-AF-2689-D3030	22e444fa-7135-4389-bad0-7f7bcdc45420	2010-11-5	5FU	NA	CHEMOTHERAPY|OTHER, SPECIFY IN NOTES	316	FALSE	346	NA	NA	NA	NA	3	VELOUR 10262 STUDY- AFLIBERCEPT/PLACEBO (4MG/KG) EVERY 2 WEEKS WITH IRINOTECAN/5FU COMBINATION (FOLFIRI)	MG	MG	NA	1	INTRAVENOUS	NA	NA	PROGRESSION	NA	10296	NA
7	335d0351-3740-4847-9ff4-be2f078c70f7	TCGA.AF.2689	TCGA-AF-2689-D2998	0cd90c9e-bd4f-4cbf-ad1d-dd6d457912e7	2010-11-5	5FU	NA	CHEMOTHERAPY	85	FALSE	267	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	7032	NA
8	335d0351-3740-4847-9ff4-be2f078c70f7	TCGA.AF.2689	TCGA-AF-2689-D2996	772bc81b-8c06-48f0-a915-68df8ceba7eb	2010-11-5	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	85	FALSE	267	NA	NA	NA	NA	12	ANCILLARY	MG	MG	600	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	7200	NA
9	335d0351-3740-4847-9ff4-be2f078c70f7	TCGA.AF.2689	TCGA-AF-2689-D3001	6dd36a05-450e-45a0-b0c5-579a3b63651b	2010-11-5	5FU	NA	CHEMOTHERAPY	85	FALSE	269	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	42192	NA
10	335d0351-3740-4847-9ff4-be2f078c70f7	TCGA.AF.2689	TCGA-AF-2689-D3024	e843e98b-59be-4d00-b606-7eaf5e9d9ac7	2010-11-5	IRINOTECAN	NA	CHEMOTHERAPY|OTHER, SPECIFY IN NOTES	316	FALSE	344	NA	NA	NA	NA	3	VELOUR 10262 STUDY- AFLIBERCEPT/PLACEBO (4MG/KG) EVERY 2 WEEKS WITH IRINOTECAN/5FU COMBINATION (FOLFIRI)	MG	MG	NA	1	INTRAVENOUS	NA	NA	PROGRESSION	NA	772	NA
11	335d0351-3740-4847-9ff4-be2f078c70f7	TCGA.AF.2689	TCGA-AF-2689-D3028	4d891da7-ccc2-4b3e-b531-0bbd6385e6a6	2010-11-5	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	316	FALSE	344	NA	NA	NA	NA	3	OTHER ANCILLARY-VELOUR 10262 STUDY- AFLIBERCEPT/PLACEBO (4MG/KG) EVERY 2 WEEKS WITH IRINOTECAN/5FU COMBINATION (FOLFIRI)	MG	MG	NA	1	INTRAVENOUS	NA	NA	PROGRESSION	NA	1716	NA
12	335d0351-3740-4847-9ff4-be2f078c70f7	TCGA.AF.2689	TCGA-AF-2689-D2997	8675aae4-8055-487a-b80a-4e53c4629f87	2010-11-5	OXALIPLATIN	NA	CHEMOTHERAPY	85	FALSE	267	NA	NA	NA	NA	11	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	707	NA
13	335d0351-3740-4847-9ff4-be2f078c70f7	TCGA.AF.2689	TCGA-AF-2689-D3029	1dcab074-5ee4-4818-89bf-d7fdd9de8818	2010-11-5	5FU	NA	CHEMOTHERAPY|OTHER, SPECIFY IN NOTES	316	FALSE	344	NA	NA	NA	NA	3	VELOUR 10262 STUDY- AFLIBERCEPT/PLACEBO (4MG/KG) EVERY 2 WEEKS WITH IRINOTECAN/5FU COMBINATION (FOLFIRI)	MG	MG	NA	1	INTRAVENOUS	NA	NA	PROGRESSION	NA	1716	NA
14	335d0351-3740-4847-9ff4-be2f078c70f7	TCGA.AF.2689	TCGA-AF-2689-D2991	5ae8e910-5b3a-4fb0-8bd2-f37b9756c396	2010-11-5	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	85	FALSE	239	NA	NA	NA	NA	10	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	2363.5	NA
15	335d0351-3740-4847-9ff4-be2f078c70f7	TCGA.AF.2689	TCGA-AF-2689-D3007	bf52814b-2808-468b-9ae6-49608c492c80	2010-11-5	AFLIBERCEPT/ PLACEBO STUDY	NA	OTHER, SPECIFY IN NOTES	316	FALSE	344	NA	NA	NA	NA	3	VELOUR 10262 STUDY- AFLIBERCEPT/PLACEBO (4MG/KG) EVERY 2 WEEKS WITH IRINOTECAN/5FU COMBINATION (FOLFIRI)	MG	MG	NA	1	INTRAVENOUS	NA	NA	PROGRESSION	NA	537	NA
16	335d0351-3740-4847-9ff4-be2f078c70f7	TCGA.AF.2689	TCGA-AF-2689-D3309	7eefebc0-11fd-4028-87c6-cab921f47ab3	2010-11-12	AVASTIN	NA	TARGETED MOLECULAR THERAPY	462	FALSE	559	NA	NA	NA	NA	NA	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
17	335d0351-3740-4847-9ff4-be2f078c70f7	TCGA.AF.2689	TCGA-AF-2689-D3307	5df65b50-c401-4ff5-af88-293a113e284a	2010-11-12	FUDR (FLOXURIDINE)	NA	CHEMOTHERAPY	379	FALSE	559	NA	NA	NA	NA	NA	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
18	335d0351-3740-4847-9ff4-be2f078c70f7	TCGA.AF.2689	TCGA-AF-2689-D3308	8c673e37-976e-454d-841d-a0888f2d93ed	2010-11-12	CAMPTOSAR	NA	CHEMOTHERAPY	379	FALSE	559	NA	NA	NA	NA	NA	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
19	335d0351-3740-4847-9ff4-be2f078c70f7	TCGA.AF.2689	TCGA-AF-2689-D4053	62a137f0-ba1f-4bfa-a6cc-cfe749a79ca4	2010-11-24	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	379	FALSE	559	NA	NA	NA	NA	NA	ANCILLARY	MG	MG	NA	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
20	71a32fca-d48f-4ea3-8df7-69f9dda8fa91	TCGA.AF.2692	TCGA-AF-2692-D9921	8d16b3a4-228c-430e-a26c-6747b843381d	2010-12-21	XELODA	NA	CHEMOTHERAPY	344	FALSE	384	NA	NA	NA	NA	NA	NA	MG	MG	1500	1	ORAL	NA	NA	RECURRENCE	NA	87000	NA
21	cbcb2141-b415-4410-8dd7-2a3cd3980a19	TCGA.AF.3400	TCGA-AF-3400-D2753	3ec1df07-49b6-45d9-abb2-137d5d95525f	2010-11-3	5FU	NA	CHEMOTHERAPY	97	FALSE	137	NA	NA	NA	NA	6	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	14005	NA
22	cbcb2141-b415-4410-8dd7-2a3cd3980a19	TCGA.AF.3400	TCGA-AF-3400-D2800	0e287f64-1843-4bfa-a0e8-19be31c3cb81	2010-11-4	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	185	FALSE	358	NA	NA	NA	NA	11	ANCILLARY	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	6850	NA
23	cbcb2141-b415-4410-8dd7-2a3cd3980a19	TCGA.AF.3400	TCGA-AF-3400-D2850	a2e12b5b-e00e-4614-aaa9-973b603d189c	2010-11-4	5-FU	NA	CHEMOTHERAPY	185	FALSE	360	NA	NA	NA	NA	11	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	44067	NA
24	cbcb2141-b415-4410-8dd7-2a3cd3980a19	TCGA.AF.3400	TCGA-AF-3400-D2833	f5420dc8-d394-4f7f-9848-008df8cbc84b	2010-11-4	OXALIPLATIN	NA	CHEMOTHERAPY	185	FALSE	358	NA	NA	NA	NA	11	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	1551	NA
25	cbcb2141-b415-4410-8dd7-2a3cd3980a19	TCGA.AF.3400	TCGA-AF-3400-D2847	2a24fcad-f207-47b7-87cf-f710d38df559	2010-11-4	5FU	NA	CHEMOTHERAPY	185	FALSE	358	NA	NA	NA	NA	11	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	7300	NA
26	17e286b7-7793-446d-b556-1108addb5ba2	TCGA.AF.3911	TCGA-AF-3911-D13478	9cf10576-9771-4a03-ab78-4c2dc302073e	2011-6-28	OXALIPLATIN	NA	CHEMOTHERAPY	145	FALSE	285	NA	NA	NA	NA	11	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	1868	NA
27	17e286b7-7793-446d-b556-1108addb5ba2	TCGA.AF.3911	TCGA-AF-3911-D13479	378a1cdd-b199-4005-b5a8-590fe60c777c	2011-6-28	5FU	NA	CHEMOTHERAPY	145	FALSE	300	NA	NA	NA	NA	12	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	10296	NA
28	17e286b7-7793-446d-b556-1108addb5ba2	TCGA.AF.3911	TCGA-AF-3911-D13480	763988bf-65bc-4af6-affa-2d62417e581e	2011-6-28	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	145	FALSE	300	NA	NA	NA	NA	12	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	6200	NA
29	17e286b7-7793-446d-b556-1108addb5ba2	TCGA.AF.3911	TCGA-AF-3911-D13481	ac0aeb25-48f3-4491-a888-09bc7cd2757f	2011-6-28	5FU	NA	CHEMOTHERAPY	145	FALSE	302	NA	NA	NA	NA	12	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	61776	NA
30	17e286b7-7793-446d-b556-1108addb5ba2	TCGA.AF.3911	TCGA-AF-3911-D13456	93f15563-e1f4-4df9-98fe-2c058fa1aef0	2011-7-18	5FU	NA	CHEMOTHERAPY	68	FALSE	106	NA	NA	NA	NA	6	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	13271	NA
31	03a9dd9d-62ae-4acd-9272-389274858f3d	TCGA.AF.3913	TCGA-AF-3913-D15342	37cd71bc-2e4e-467d-8695-ebb6dae9c2e0	2011-9-19	XELODA	NA	CHEMOTHERAPY	231	FALSE	313	NA	NA	NA	NA	3	NA	NA	NA	NA	1	ORAL	NA	NA	PALLIATIVE	NA	NA	NA
32	03a9dd9d-62ae-4acd-9272-389274858f3d	TCGA.AF.3913	TCGA-AF-3913-D15339	55dec849-87fa-4e9d-b34a-25d3f86fd865	2011-9-19	OXALIPLATIN	NA	CHEMOTHERAPY	231	FALSE	313	NA	NA	NA	NA	3	NA	NA	NA	NA	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	NA	NA
33	3f2ca278-c74a-4aa7-b029-189d9d0b510c	TCGA.AF.3914	TCGA-AF-3914-D10865	742fb3eb-c8eb-4377-ad4b-8f106d302e97	2011-4-28	OXALIPLATIN	NA	CHEMOTHERAPY	133	FALSE	294	NA	NA	NA	NA	12	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	1643	NA
34	3f2ca278-c74a-4aa7-b029-189d9d0b510c	TCGA.AF.3914	TCGA-AF-3914-D10887	70ef1e70-9652-476a-a268-1280652bb1a8	2011-4-28	5 FU	NA	CHEMOTHERAPY	133	FALSE	294	NA	NA	NA	NA	12	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	7918	NA
35	3f2ca278-c74a-4aa7-b029-189d9d0b510c	TCGA.AF.3914	TCGA-AF-3914-D10888	9f639bf0-67cc-4ca3-a738-c7f03a214b21	2011-4-28	5 FU	NA	CHEMOTHERAPY	133	FALSE	296	NA	NA	NA	NA	12	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
36	3f2ca278-c74a-4aa7-b029-189d9d0b510c	TCGA.AF.3914	TCGA-AF-3914-D10886	caf0a7a9-d006-46fa-9810-3cb754a26c74	2011-4-28	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	133	FALSE	294	NA	NA	NA	NA	12	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	3150	NA
37	3f2ca278-c74a-4aa7-b029-189d9d0b510c	TCGA.AF.3914	TCGA-AF-3914-D10864	359d8f95-b037-463b-bebb-679c31c0ef3e	2011-4-28	5 FU	NA	CHEMOTHERAPY	61	FALSE	105	NA	NA	NA	NA	7	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	12265	NA
38	3f2ca278-c74a-4aa7-b029-189d9d0b510c	TCGA.AF.3914	TCGA-AF-3914-D41485	AC84D228-12BE-44DA-A004-F09C1B574F03	2013-3-19	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	924	FALSE	1134	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
39	3f2ca278-c74a-4aa7-b029-189d9d0b510c	TCGA.AF.3914	TCGA-AF-3914-D41486	9BF0B463-F451-4BB4-BB19-1675656AE60F	2013-3-19	LEUCOVORIN	NA	ANCILLARY	924	FALSE	1022	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
40	3f2ca278-c74a-4aa7-b029-189d9d0b510c	TCGA.AF.3914	TCGA-AF-3914-D41487	DB0F22AA-0122-4C85-9E00-07A45715A0B0	2013-3-19	OXALIPLATIN	NA	CHEMOTHERAPY	924	FALSE	1022	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
41	3f2ca278-c74a-4aa7-b029-189d9d0b510c	TCGA.AF.3914	TCGA-AF-3914-D41488	E946FC49-AEB3-4A51-B943-CDA7CC4A7A31	2013-3-19	FLUOROURACIL	NA	CHEMOTHERAPY	924	FALSE	1022	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
42	3f2ca278-c74a-4aa7-b029-189d9d0b510c	TCGA.AF.3914	TCGA-AF-3914-D41489	A35156FA-AFFB-498C-AE11-E35ECC46908E	2013-3-19	FLUOROURACIL IV CONTINUOUS INFUSION OVER 46 HOURS	NA	CHEMOTHERAPY	924	FALSE	1024	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
43	5f10f8e4-a6f9-4643-b210-390bc8fd32bd	TCGA.AF.4110	TCGA-AF-4110-D13664	0916a9a1-c34b-4f5f-82d9-bd1d903c605e	2011-7-7	5FU	NA	CHEMOTHERAPY	65	FALSE	261	NA	NA	NA	NA	9	NA	MG	MG	875	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	7875	NA
44	5f10f8e4-a6f9-4643-b210-390bc8fd32bd	TCGA.AF.4110	TCGA-AF-4110-D13665	ea9270b1-82ca-4900-a127-946f0ec99902	2011-7-7	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	65	FALSE	261	NA	NA	NA	NA	9	LEUCOVORIN	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	5875	NA
45	5f10f8e4-a6f9-4643-b210-390bc8fd32bd	TCGA.AF.4110	TCGA-AF-4110-D13666	cbc1140c-d519-4b62-90fa-5fe35623fa70	2011-7-7	5FU	NA	CHEMOTHERAPY	65	FALSE	263	NA	NA	NA	NA	9	NA	MG	MG	5200	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	46800	NA
46	5f10f8e4-a6f9-4643-b210-390bc8fd32bd	TCGA.AF.4110	TCGA-AF-4110-D13658	8e82086a-6e5b-4fd9-b884-c08049426228	2011-7-7	OXALIPLATIN	NA	CHEMOTHERAPY	65	FALSE	261	NA	NA	NA	NA	9	NA	MG	MG	185	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1665	NA
47	5bc1db25-3e25-44d7-99cb-e31f00cf1d58	TCGA.AF.6136	TCGA-AF-6136-D31526	6a8a2d9a-dceb-4ed9-8bfc-76a4c6c10c28	2012-5-9	OXALIPLATIN	NA	CHEMOTHERAPY	209	FALSE	385	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
48	5bc1db25-3e25-44d7-99cb-e31f00cf1d58	TCGA.AF.6136	TCGA-AF-6136-D31527	54ada04a-3ac3-487d-b98b-814256e83be5	2012-5-9	LEUCOVORIN	NA	ANCILLARY	209	FALSE	454	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
49	5bc1db25-3e25-44d7-99cb-e31f00cf1d58	TCGA.AF.6136	TCGA-AF-6136-D31528	1419103a-d51d-4461-bb13-1a18acce6ed3	2012-5-9	FLUOROURACIL	NA	CHEMOTHERAPY	209	FALSE	454	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
50	5bc1db25-3e25-44d7-99cb-e31f00cf1d58	TCGA.AF.6136	TCGA-AF-6136-D31529	b031c881-0b3e-4778-bc63-28d0e2bf4c48	2012-5-9	FLUOROURACIL	NA	CHEMOTHERAPY	209	FALSE	453	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
51	5bc1db25-3e25-44d7-99cb-e31f00cf1d58	TCGA.AF.6136	TCGA-AF-6136-D31525	e005c38c-40ff-4493-815b-770c79d550ad	2012-5-11	FLUOROURACIL	NA	CHEMOTHERAPY	117	FALSE	117	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
52	6221496d-40cc-4071-969f-6fbcba4f573c	TCGA.AF.6672	TCGA-AF-6672-D19807	dac0f8bc-2057-4165-bc75-9907572612fc	2011-12-27	FLUOROURACIL	NA	CHEMOTHERAPY	43	FALSE	199	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	51786	NA
53	6221496d-40cc-4071-969f-6fbcba4f573c	TCGA.AF.6672	TCGA-AF-6672-D19804	3bf645a0-d4bb-4afe-85e0-bfbe69b64c7e	2011-12-27	OXALIPLATIN	NA	CHEMOTHERAPY	43	FALSE	183	NA	NA	NA	NA	11	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1578	NA
54	6221496d-40cc-4071-969f-6fbcba4f573c	TCGA.AF.6672	TCGA-AF-6672-D19805	6ff436f2-b6b7-4a69-a1aa-cbc6fe45a89f	2011-12-27	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	43	FALSE	197	NA	NA	NA	NA	12	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1400	NA
55	6221496d-40cc-4071-969f-6fbcba4f573c	TCGA.AF.6672	TCGA-AF-6672-D19806	5d946f3e-2226-4819-bca2-6f6831cae629	2011-12-27	FLUOROURACIL	NA	CHEMOTHERAPY	43	FALSE	197	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	8639	NA
56	C8FD1040-82A2-4CDA-AC49-C2F82B20CBAB	TCGA.AF.A56L	TCGA-AF-A56L-D42409	B297C576-C11B-4810-B6C6-C2859AF3D1DE	2013-4-18	OXALIPLATIN	NA	CHEMOTHERAPY	52	FALSE	255	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
57	C8FD1040-82A2-4CDA-AC49-C2F82B20CBAB	TCGA.AF.A56L	TCGA-AF-A56L-D42410	C6E884C2-2F25-4791-8E07-CF6A9034F43D	2013-4-18	LEUCOVORIN	NA	ANCILLARY	52	FALSE	255	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
58	C8FD1040-82A2-4CDA-AC49-C2F82B20CBAB	TCGA.AF.A56L	TCGA-AF-A56L-D42411	B413308D-C7F5-4902-8FF1-D44C8696D792	2013-4-18	5FU	NA	CHEMOTHERAPY	52	FALSE	255	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
59	C8FD1040-82A2-4CDA-AC49-C2F82B20CBAB	TCGA.AF.A56L	TCGA-AF-A56L-D42412	7CF68531-04CC-4FC7-B1CA-17DB824739E0	2013-4-18	5FU	NA	CHEMOTHERAPY	52	FALSE	255	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
60	811F3FEB-A5A9-48B1-ACDA-FBB23FCBCF16	TCGA.AF.A56N	TCGA-AF-A56N-D42111	5A29766B-D0E7-47E8-BB9B-21A9A9E7F331	2013-4-11	XELODA	NA	CHEMOTHERAPY	54	FALSE	95	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
61	811F3FEB-A5A9-48B1-ACDA-FBB23FCBCF16	TCGA.AF.A56N	TCGA-AF-A56N-D42114	9BCDA4FD-AF03-4003-9FD6-36343C7BB81C	2013-4-11	XELODA	NA	CHEMOTHERAPY	159	FALSE	347	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
62	b2c48624-a483-4b1d-9155-c0c80ed2f7a0	TCGA.AG.3584	TCGA-AG-3584-D37619	FB261DCE-FD6C-4A15-AA2E-ABE3012E6B22	2012-12-5	FOLINIC ACID	NA	CHEMOTHERAPY	92	FALSE	274	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
63	b2c48624-a483-4b1d-9155-c0c80ed2f7a0	TCGA.AG.3584	TCGA-AG-3584-D37620	079392F9-28CE-40D9-8097-908D753F5F41	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	92	FALSE	274	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
64	b2c48624-a483-4b1d-9155-c0c80ed2f7a0	TCGA.AG.3584	TCGA-AG-3584-D37621	1B4F9FA3-8976-4771-B187-EAFB66D56DB9	2012-12-5	IRINOTECAN	NA	CHEMOTHERAPY	92	FALSE	274	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
65	b2c48624-a483-4b1d-9155-c0c80ed2f7a0	TCGA.AG.3584	TCGA-AG-3584-D37622	A2894A8C-69C0-42F7-8A2F-F63A9150C893	2012-12-5	FOLINIC ACID	NA	CHEMOTHERAPY	335	FALSE	396	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
66	b2c48624-a483-4b1d-9155-c0c80ed2f7a0	TCGA.AG.3584	TCGA-AG-3584-D37623	6B518DAA-0328-44A6-902E-ED9122718F0D	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	335	FALSE	396	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
67	b2c48624-a483-4b1d-9155-c0c80ed2f7a0	TCGA.AG.3584	TCGA-AG-3584-D37624	5C31B440-ED68-435C-89C1-337C2C1B9498	2012-12-5	OXALIPLATIN	NA	CHEMOTHERAPY	335	FALSE	396	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
68	b2c48624-a483-4b1d-9155-c0c80ed2f7a0	TCGA.AG.3584	TCGA-AG-3584-D37625	C91698E7-82FD-4FD9-B3C7-50E589A064F5	2012-12-5	IRINOTECAN	NA	CHEMOTHERAPY	427	FALSE	580	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
69	b2c48624-a483-4b1d-9155-c0c80ed2f7a0	TCGA.AG.3584	TCGA-AG-3584-D37626	7F381F5C-41AD-4C61-974F-48B497AA77D4	2012-12-5	IRINOTECAN	NA	CHEMOTHERAPY	427	FALSE	580	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
70	b2c48624-a483-4b1d-9155-c0c80ed2f7a0	TCGA.AG.3584	TCGA-AG-3584-D37627	B834783E-DAAC-45FF-9BDC-028EB4A7A879	2012-12-5	IRINOTECAN	NA	CHEMOTHERAPY	427	FALSE	580	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
71	a2b6246d-2b80-49c5-968b-694b4e8171dc	TCGA.AG.3591	TCGA-AG-3591-D37628	08A34556-1CC3-4842-91F9-25E1D7455F1E	2012-12-5	NA	NA	CHEMOTHERAPY	NA	NA	NA	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
72	10290e91-9784-4f94-8daa-b5d9a8b0efb9	TCGA.AG.3593	TCGA-AG-3593-D37629	F0328A7A-9B62-404F-AC16-CA9495F2E404	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	61	FALSE	92	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
73	17a8d208-fcf6-4480-945c-848d4234aafd	TCGA.AG.3600	TCGA-AG-3600-D37630	69707452-630C-4BFE-A48F-B625078F02D9	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	31	FALSE	92	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
74	81dac02c-6e5f-4afe-9c90-12b5a4f26594	TCGA.AG.3609	TCGA-AG-3609-D37631	DA3F2436-7363-4949-967D-5030F2F0C5D2	2012-12-5	FOLINIC ACID	NA	CHEMOTHERAPY	31	FALSE	212	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
75	81dac02c-6e5f-4afe-9c90-12b5a4f26594	TCGA.AG.3609	TCGA-AG-3609-D37632	5E269C7F-6E92-4C6D-BC05-F089CC7FCA62	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	31	FALSE	212	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
76	81dac02c-6e5f-4afe-9c90-12b5a4f26594	TCGA.AG.3609	TCGA-AG-3609-D37633	AE9AEFB7-BB2B-4B63-B031-2CAF2DB86DC3	2012-12-5	OXALIPLATIN	NA	CHEMOTHERAPY	31	FALSE	90	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
77	fb632146-92c7-40d9-acc3-6dc4a2d499be	TCGA.AG.3611	TCGA-AG-3611-D37634	40EA7062-DFF9-4BC9-9EBA-7AF603EFA401	2012-12-5	FOLINIC ACID	NA	CHEMOTHERAPY	850	FALSE	973	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
78	fb632146-92c7-40d9-acc3-6dc4a2d499be	TCGA.AG.3611	TCGA-AG-3611-D37635	0D72C3B9-12DB-45F9-8E9B-575140447392	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	850	FALSE	973	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
79	1543c1da-bde4-41c1-a510-56b62db8cca8	TCGA.AG.3612	TCGA-AG-3612-D37636	C4769825-6F3B-421E-B75C-5FEFBE760F7A	2012-12-5	FOLINIC ACID	NA	CHEMOTHERAPY	59	FALSE	273	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
80	1543c1da-bde4-41c1-a510-56b62db8cca8	TCGA.AG.3612	TCGA-AG-3612-D37637	ED6FBE6C-F021-4A62-8F36-809D25748C6B	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	59	FALSE	273	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
81	1543c1da-bde4-41c1-a510-56b62db8cca8	TCGA.AG.3612	TCGA-AG-3612-D37638	24C1B6B1-A537-45CC-AFFF-36F91F5F59D9	2012-12-5	OXALIPLATIN	NA	CHEMOTHERAPY	59	FALSE	212	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
82	856a490c-c6da-48fe-88b5-9fde0f481365	TCGA.AG.3728	TCGA-AG-3728-D37639	53588706-BC6B-405C-A6D2-4C7953641320	2012-12-5	FOLINIC ACID	NA	CHEMOTHERAPY	61	FALSE	61	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
83	856a490c-c6da-48fe-88b5-9fde0f481365	TCGA.AG.3728	TCGA-AG-3728-D37640	73B9ADC4-8BF1-4085-B885-844051A7F688	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	61	FALSE	61	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
84	856a490c-c6da-48fe-88b5-9fde0f481365	TCGA.AG.3728	TCGA-AG-3728-D37641	294E64A4-AE56-42C8-A708-559C0DD9689A	2012-12-5	OXALIPLATIN	NA	CHEMOTHERAPY	61	FALSE	61	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
85	72756208-a5ed-47d2-8c4c-19a8d39f7b9d	TCGA.AG.3731	TCGA-AG-3731-D37642	89CD8582-B07D-4C29-ABEB-E59268AC7FD7	2012-12-5	FOLINIC ACID	NA	CHEMOTHERAPY	92	FALSE	914	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
86	72756208-a5ed-47d2-8c4c-19a8d39f7b9d	TCGA.AG.3731	TCGA-AG-3731-D37643	0050963E-70D9-4754-BD4D-5CB6943EDB8A	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	92	FALSE	914	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
87	72756208-a5ed-47d2-8c4c-19a8d39f7b9d	TCGA.AG.3731	TCGA-AG-3731-D37644	D24F50D6-FB52-4277-8AB4-AC5123C639C7	2012-12-5	OXALIPLATIN	NA	CHEMOTHERAPY	92	FALSE	184	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
88	72756208-a5ed-47d2-8c4c-19a8d39f7b9d	TCGA.AG.3731	TCGA-AG-3731-D37645	ABCED613-88E1-44F3-8477-B6B2A8C63CF9	2012-12-5	IRINOTECAN	NA	CHEMOTHERAPY	365	FALSE	914	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
89	a83923fd-276c-4526-9922-5ef741f551fd	TCGA.AG.3732	TCGA-AG-3732-D37646	E3DA3054-7188-4C70-B09A-AAE3757CB1F5	2012-12-5	CAPECITABINE	NA	CHEMOTHERAPY	1277	FALSE	1673	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
90	a83923fd-276c-4526-9922-5ef741f551fd	TCGA.AG.3732	TCGA-AG-3732-D37647	F553079B-0B3B-485C-A8D3-B2D83729DB97	2012-12-5	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	1277	FALSE	1673	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
91	e5e4aa9f-6015-4d62-a088-69920d7f2500	TCGA.AG.3885	TCGA-AG-3885-D37648	C4BBC4E0-3D66-4633-A05D-4A68AE87C8A7	2012-12-5	NA	NA	CHEMOTHERAPY	NA	NA	NA	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
92	e5e4aa9f-6015-4d62-a088-69920d7f2500	TCGA.AG.3885	TCGA-AG-3885-D37649	78CE6B50-B0DA-403C-A9CF-FFF157A9C0CC	2012-12-5	ZOLEDRONIC ACID	NA	ANCILLARY	365	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
93	8c7ccdb0-7653-4a8d-86b6-de39afc40765	TCGA.AG.3887	TCGA-AG-3887-D37650	B21661DA-72BC-41E0-8FB1-7FD3C9904564	2012-12-5	IRINOTECAN	NA	CHEMOTHERAPY	1095	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
94	8c7ccdb0-7653-4a8d-86b6-de39afc40765	TCGA.AG.3887	TCGA-AG-3887-D37651	D19E88BF-FD23-407D-8687-8DBC9EF02F86	2012-12-5	CAPECITABINE	NA	CHEMOTHERAPY	1095	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
95	8c7ccdb0-7653-4a8d-86b6-de39afc40765	TCGA.AG.3887	TCGA-AG-3887-D37652	8EDBD3BB-086B-4166-A971-A245C564BF9C	2012-12-5	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	1095	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
96	add567b7-29ef-4122-8a54-57d36f735e78	TCGA.AG.3893	TCGA-AG-3893-D37653	D8A5AC42-4F51-4626-BFAB-BF6CD4C44D3C	2012-12-5	FOLINIC ACID	NA	CHEMOTHERAPY	61	FALSE	245	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
97	add567b7-29ef-4122-8a54-57d36f735e78	TCGA.AG.3893	TCGA-AG-3893-D37654	1680F252-BB88-454F-B1CC-FE1038F33269	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	61	FALSE	245	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
98	065b26fc-6827-44d5-83d8-1100c63fcda6	TCGA.AG.3894	TCGA-AG-3894-D37655	E4102A2F-8A6F-4B7C-9E20-3970FC3DD124	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	61	FALSE	245	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
99	769880ae-34d9-405e-8ea7-33ba47cf2dd2	TCGA.AG.3909	TCGA-AG-3909-D37656	9844876F-EB16-49BC-86DC-FCCAC4BD3B19	2012-12-5	FOLINIC ACID	NA	CHEMOTHERAPY	62	FALSE	243	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
100	769880ae-34d9-405e-8ea7-33ba47cf2dd2	TCGA.AG.3909	TCGA-AG-3909-D37657	AAB0F90D-B954-464B-9589-2484E0399046	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	62	FALSE	243	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
101	769880ae-34d9-405e-8ea7-33ba47cf2dd2	TCGA.AG.3909	TCGA-AG-3909-D37658	117DFF8F-E037-4B98-8108-AB8562BC27F8	2012-12-5	OXALIPLATIN	NA	CHEMOTHERAPY	62	FALSE	182	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
102	60778da8-d99e-4e51-96a2-3e900b3978d9	TCGA.AG.3999	TCGA-AG-3999-D37659	4C69C48C-88A7-428F-85CB-0897E5F61623	2012-12-5	NA	NA	CHEMOTHERAPY	NA	NA	NA	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
103	866de12b-e4df-4f19-b62e-e3fd85d4ec08	TCGA.AG.4005	TCGA-AG-4005-D37660	217AFF88-4D43-42A3-9A3E-16D1662C2D28	2012-12-5	FOLINIC ACID	NA	CHEMOTHERAPY	61	FALSE	213	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
104	866de12b-e4df-4f19-b62e-e3fd85d4ec08	TCGA.AG.4005	TCGA-AG-4005-D37661	DB8463A1-4C26-4AC4-9DEE-7392B21B8AA6	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	61	FALSE	213	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
105	866de12b-e4df-4f19-b62e-e3fd85d4ec08	TCGA.AG.4005	TCGA-AG-4005-D37662	380000BA-B2B9-4D32-BA25-4E518DE0341C	2012-12-5	OXALIPLATIN	NA	CHEMOTHERAPY	61	FALSE	213	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
106	72802851-9340-4c5f-a90b-23b7afd7577a	TCGA.AG.4008	TCGA-AG-4008-D37663	5DD8AC7E-EEB1-4222-99A5-6B18A6A0B3CD	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	61	FALSE	92	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
107	72802851-9340-4c5f-a90b-23b7afd7577a	TCGA.AG.4008	TCGA-AG-4008-D37664	E2E9F3AE-4CA2-4A37-B87C-AD62DCF39099	2012-12-5	FOLINIC ACID	NA	CHEMOTHERAPY	61	FALSE	92	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
108	9084b672-8e65-4b7f-a256-32fd35aa8ab5	TCGA.AG.4022	TCGA-AG-4022-D37665	BA0BE627-3B95-403A-954D-635201C79CD6	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	61	FALSE	153	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
109	ff004403-8cc5-43e6-bd1c-dde4eb1e6193	TCGA.AG.A00C	TCGA-AG-A00C-D37666	0480C952-95AB-4119-B285-88C9B48B46CF	2012-12-5	FOLINIC ACID	NA	CHEMOTHERAPY	92	FALSE	213	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
110	ff004403-8cc5-43e6-bd1c-dde4eb1e6193	TCGA.AG.A00C	TCGA-AG-A00C-D37667	AB4C44C6-717B-46CA-8881-BCDB2B3C9D28	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	61	FALSE	213	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
111	ff004403-8cc5-43e6-bd1c-dde4eb1e6193	TCGA.AG.A00C	TCGA-AG-A00C-D37668	66F94F54-0A6F-4BA1-8050-01A385AB66F3	2012-12-5	OXALIPLATIN	NA	CHEMOTHERAPY	92	FALSE	213	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
112	9f4574ec-a58a-4410-8735-c5e5bc4ca7e0	TCGA.AG.A00H	TCGA-AG-A00H-D37669	F74BAE20-BD17-4DF8-9A05-AF806FEAA77A	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	90	FALSE	121	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
113	9c7b5e85-5579-4d0f-a7ea-b9d081ac0037	TCGA.AG.A016	TCGA-AG-A016-D37670	D17DDE62-D61E-4DC5-B0BD-069B51F864DC	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	31	FALSE	245	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
114	9c7b5e85-5579-4d0f-a7ea-b9d081ac0037	TCGA.AG.A016	TCGA-AG-A016-D37671	078B47FD-21FB-4FD2-8F32-E9DD57433938	2012-12-5	FOLINIC ACID	NA	CHEMOTHERAPY	31	FALSE	61	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
115	9c7b5e85-5579-4d0f-a7ea-b9d081ac0037	TCGA.AG.A016	TCGA-AG-A016-D37672	A029C8B8-87C1-462D-B804-E918A20290E6	2012-12-5	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	61	FALSE	245	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
116	848a5838-8a06-45a9-a3d6-e4ed47b824ab	TCGA.AG.A01L	TCGA-AG-A01L-D37673	8D57ECE2-11F5-4F08-8457-0FE7CAE7E643	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	61	FALSE	212	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
117	1118490d-75aa-43cc-b2a2-c2af61829ffc	TCGA.AG.A01N	TCGA-AG-A01N-D37674	8793E6F8-2AE4-419F-82DA-05F1528C6AF6	2012-12-5	CAPECITABINE	NA	CHEMOTHERAPY	273	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
118	1118490d-75aa-43cc-b2a2-c2af61829ffc	TCGA.AG.A01N	TCGA-AG-A01N-D37675	E059357B-5A89-48CC-B169-E79CDB764464	2012-12-5	OXALIPLATIN	NA	CHEMOTHERAPY	273	FALSE	457	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
119	1118490d-75aa-43cc-b2a2-c2af61829ffc	TCGA.AG.A01N	TCGA-AG-A01N-D37676	227136E0-CD9A-4B79-9777-3212A6324483	2012-12-5	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	273	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
120	74543fa4-ce73-46e4-9c59-224e8242b4a2	TCGA.AG.A01W	TCGA-AG-A01W-D37677	E11038FD-3C7C-46DA-A03B-2AB5352DCDD5	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	62	FALSE	184	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
121	a91f7a8c-e0fe-403a-9ef0-f7679b2761cc	TCGA.AG.A01Y	TCGA-AG-A01Y-D37678	F99733D4-0119-416D-BCC9-791AD546EB61	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	31	FALSE	151	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
122	19e46a3d-18c5-4927-8501-2265e2d617b8	TCGA.AG.A020	TCGA-AG-A020-D37679	AD098A28-2DA7-4BED-A331-5AA7358A8D28	2012-12-5	FOLINIC ACID	NA	CHEMOTHERAPY	31	FALSE	212	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
123	19e46a3d-18c5-4927-8501-2265e2d617b8	TCGA.AG.A020	TCGA-AG-A020-D37680	3881A04C-1D82-4DD6-B894-53A283C12CBE	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	31	FALSE	212	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
124	19e46a3d-18c5-4927-8501-2265e2d617b8	TCGA.AG.A020	TCGA-AG-A020-D37681	D2ADA08C-069D-430C-9642-E1F7DCC0513E	2012-12-5	OXALIPLATIN	NA	CHEMOTHERAPY	31	FALSE	212	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
125	17878cb0-a8f9-43a4-911c-0f94c2a5e3df	TCGA.AG.A02G	TCGA-AG-A02G-D37682	7458F01A-6F47-42AC-AB9F-525BFC8D3A2F	2012-12-5	FOLINIC ACID	NA	CHEMOTHERAPY	28	TRUE	1096	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
126	17878cb0-a8f9-43a4-911c-0f94c2a5e3df	TCGA.AG.A02G	TCGA-AG-A02G-D37683	A6893A84-4202-474B-9A3D-78E7E865113C	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	28	FALSE	1096	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
127	17878cb0-a8f9-43a4-911c-0f94c2a5e3df	TCGA.AG.A02G	TCGA-AG-A02G-D37684	A8310B34-29AD-410D-A5DE-FCDD7CBE7AEE	2012-12-5	IRINOTECAN	NA	CHEMOTHERAPY	28	FALSE	242	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
128	17878cb0-a8f9-43a4-911c-0f94c2a5e3df	TCGA.AG.A02G	TCGA-AG-A02G-D37685	E6F1FA31-3AF9-45D0-A70B-38EF81B6A288	2012-12-5	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	28	FALSE	242	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
129	17878cb0-a8f9-43a4-911c-0f94c2a5e3df	TCGA.AG.A02G	TCGA-AG-A02G-D37686	2DCEA1E6-7D2F-46E0-9D15-4069C8FFC067	2012-12-5	OXALIPLATIN	NA	CHEMOTHERAPY	851	FALSE	1096	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
130	8ad1c98b-5395-477e-87a8-19dff3a59c26	TCGA.AG.A02N	TCGA-AG-A02N-D37687	EB905BAF-E8D7-417B-AA1A-5FA9303ABF20	2012-12-5	FOLINIC ACID	NA	CHEMOTHERAPY	28	FALSE	89	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
131	0bb786ee-07cf-4853-9b49-ec95cd14e282	TCGA.AG.A032	TCGA-AG-A032-D37688	E547F9F9-E8C7-444D-9948-84C39401718F	2012-12-5	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	458	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
132	f2a8deb2-0e2c-4bbd-8fa1-99b7abb2f3aa	TCGA.AG.A036	TCGA-AG-A036-D37689	5C971E83-8B85-45AE-86A7-2658BC205B5F	2012-12-5	5-FLUOROURACIL	NA	CHEMOTHERAPY	92	FALSE	215	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
133	835cbd02-4dbb-4273-9704-4b5d272493d7	TCGA.AH.6544	TCGA-AH-6544-D58962	A7E20535-8B56-47B9-9317-056575B2B34A	2014-4-29	OXALIPLATIN	NA	CHEMOTHERAPY	68	FALSE	229	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
134	835cbd02-4dbb-4273-9704-4b5d272493d7	TCGA.AH.6544	TCGA-AH-6544-D58963	E0872852-6AFB-4304-9F95-06C0DAE1CC66	2014-4-29	AVASTIN	NA	CHEMOTHERAPY	68	FALSE	365	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
135	835cbd02-4dbb-4273-9704-4b5d272493d7	TCGA.AH.6544	TCGA-AH-6544-D58964	26178324-9337-4FDE-9138-4CB722F26575	2014-4-29	XELODA	NA	CHEMOTHERAPY	243	FALSE	365	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
136	835cbd02-4dbb-4273-9704-4b5d272493d7	TCGA.AH.6544	TCGA-AH-6544-D72541	1ED54217-BFD1-4649-BA20-441ACCFBBF6D	2015-7-13	5-FU	NA	CHEMOTHERAPY	68	FALSE	229	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
137	835cbd02-4dbb-4273-9704-4b5d272493d7	TCGA.AH.6544	TCGA-AH-6544-D72542	135340EA-B051-4018-8B82-1B4FDE8149C5	2015-7-13	LEUCOVORIN	NA	ANCILLARY	68	FALSE	229	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
138	bd0ddc1e-ba3b-4719-a2fa-776f0475dd8a	TCGA.AH.6643	TCGA-AH-6643-D57835	A3494B7C-E0B1-4449-A8D8-3C4470AF9AB4	2014-3-27	OXALIPLATIN	NA	CHEMOTHERAPY	41	FALSE	202	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
139	bd0ddc1e-ba3b-4719-a2fa-776f0475dd8a	TCGA.AH.6643	TCGA-AH-6643-D57836	8010F585-8B53-441B-9465-DED992A7E34E	2014-3-27	5-FU	NA	CHEMOTHERAPY	41	FALSE	202	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
140	bd0ddc1e-ba3b-4719-a2fa-776f0475dd8a	TCGA.AH.6643	TCGA-AH-6643-D57837	85D44224-0FAD-4FD4-B75C-8AFCAF6CBF8D	2014-3-27	LEUCOVORIN	NA	ANCILLARY	41	FALSE	202	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
141	1e89c189-7c8a-44c9-9b0f-2f625a285003	TCGA.AH.6903	TCGA-AH-6903-D45595	0136A943-A156-450D-89CE-22B658D58AED	2013-7-17	5-FU	NA	CHEMOTHERAPY	70	FALSE	228	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
142	1e89c189-7c8a-44c9-9b0f-2f625a285003	TCGA.AH.6903	TCGA-AH-6903-D45596	3AC71EE5-4B1E-4DBE-856A-2B4841E4EDEE	2013-7-17	OXALIPLATIN	NA	CHEMOTHERAPY	70	FALSE	228	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
143	1e89c189-7c8a-44c9-9b0f-2f625a285003	TCGA.AH.6903	TCGA-AH-6903-D45597	A49CFDD2-967B-4FC3-8902-594DAA1A2F3A	2013-7-17	LEUCOVORIN	NA	ANCILLARY	70	FALSE	228	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
144	a46be4e1-260c-4ce9-8b0f-1326d90c697f	TCGA.BM.6198	TCGA-BM-6198-D13221	50c06958-f062-4dd4-8af3-2e20727551da	2011-6-21	XELODA	NA	CHEMOTHERAPY	78	FALSE	261	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	ORAL	NA	NA	ADJUVANT	NA	NA	NA
145	b26143d3-d458-4d5c-8446-fd2f05707352	TCGA.CI.6620	TCGA-CI-6620-D69556	1F45E610-2ED5-4BF2-9A0B-213C8802E4ED	2015-1-13	LEUCOVORIN	NA	ANCILLARY	39	FALSE	160	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
146	b26143d3-d458-4d5c-8446-fd2f05707352	TCGA.CI.6620	TCGA-CI-6620-D69557	9B427929-3285-4A24-8FDD-0ADFCB371A7B	2015-1-13	FLUOROURACIL	NA	CHEMOTHERAPY	39	FALSE	160	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
147	b26143d3-d458-4d5c-8446-fd2f05707352	TCGA.CI.6620	TCGA-CI-6620-D69558	ED3B3488-DA97-4D97-A0A2-C1E0F5900F16	2015-1-13	OXALIPLATIN	NA	CHEMOTHERAPY	39	FALSE	160	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
148	bd6877a8-06b4-4b95-bed2-15c524068f21	TCGA.CI.6622	TCGA-CI-6622-D69594	456BA3A9-364D-4109-AB4E-6E5E75B906F2	2015-1-14	FLUOROURACIL	NA	CHEMOTHERAPY	65	FALSE	97	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
149	bd6877a8-06b4-4b95-bed2-15c524068f21	TCGA.CI.6622	TCGA-CI-6622-D69595	852704E9-6A87-4723-A643-5414DEE6DAEC	2015-1-14	LEUOCVORIN	NA	CHEMOTHERAPY	116	FALSE	269	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
150	bd6877a8-06b4-4b95-bed2-15c524068f21	TCGA.CI.6622	TCGA-CI-6622-D69596	8DD9165C-7657-44D3-9DB9-AF09646B5A24	2015-1-14	FLUOROURACIL	NA	CHEMOTHERAPY	116	FALSE	269	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
151	bd6877a8-06b4-4b95-bed2-15c524068f21	TCGA.CI.6622	TCGA-CI-6622-D69597	7E3E8841-F487-467D-AFFE-BA3623C3803B	2015-1-14	OXALIPLATIN	NA	CHEMOTHERAPY	116	FALSE	269	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
152	a2e47568-eb43-4c89-ad7c-dfbaa2ba7e27	TCGA.CL.4957	TCGA-CL-4957-D10094	c60e340b-0248-41fe-80fd-cef4fac101f3	2011-4-00	OXALIPLATIN	NA	CHEMOTHERAPY	42	FALSE	73	NA	NA	NA	NA	3	NA	MG/M2	NA	65	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
153	a2e47568-eb43-4c89-ad7c-dfbaa2ba7e27	TCGA.CL.4957	TCGA-CL-4957-D10096	d4aea7da-592a-47ce-ae43-a801599416d4	2011-4-00	FLUOROURACIL	NA	CHEMOTHERAPY	42	FALSE	73	NA	NA	NA	NA	3	NA	MG/M2	NA	400	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
154	a2e47568-eb43-4c89-ad7c-dfbaa2ba7e27	TCGA.CL.4957	TCGA-CL-4957-D10097	287ad8e2-f73e-4ece-ab30-2fe789f2d532	2011-4-00	LEUCOVORIN CALCIUM	NA	CHEMOTHERAPY	42	FALSE	73	NA	NA	NA	NA	3	NA	MG/M2	NA	400	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
155	a2e47568-eb43-4c89-ad7c-dfbaa2ba7e27	TCGA.CL.4957	TCGA-CL-4957-D10095	001b65f0-aff7-4cb6-bf83-050f9370e6ae	2011-4-7	FLUOROURACIL	NA	CHEMOTHERAPY	42	FALSE	73	NA	NA	NA	NA	3	NA	MG	NA	1200	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
156	644571e9-b8e6-42f3-a2e4-33bad0fac661	TCGA.DC.4745	TCGA-DC-4745-D16792	3ba36058-d0eb-40b6-b5b6-1a57dc54e5ef	2011-9-26	FLUOROURACIL	NA	CHEMOTHERAPY	62	FALSE	216	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	29000	NA
157	644571e9-b8e6-42f3-a2e4-33bad0fac661	TCGA.DC.4745	TCGA-DC-4745-D16799	5935d581-743c-4b5e-892c-f90ab7754666	2011-9-26	PEGFILGRASTIM	NA	OTHER, SPECIFY IN NOTES	122	FALSE	204	NA	NA	NA	NA	6	ANCILLARY	MG	MG	6	1	SUBCUTANEOUS	NA	NA	ADJUVANT	NA	36	NA
158	644571e9-b8e6-42f3-a2e4-33bad0fac661	TCGA.DC.4745	TCGA-DC-4745-D16789	56e97bd0-ae1f-4321-9da2-1c4fcebd711d	2011-9-26	FLUOROURACIL	NA	CHEMOTHERAPY	62	FALSE	216	NA	NA	NA	NA	12	NA	MG	MG	800	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9600	NA
159	644571e9-b8e6-42f3-a2e4-33bad0fac661	TCGA.DC.4745	TCGA-DC-4745-D16795	2e038d05-efc6-45e4-b011-af9a6669eda3	2011-9-26	LEUCOVORIN CALCIUM	NA	OTHER, SPECIFY IN NOTES	62	FALSE	216	NA	NA	NA	NA	12	ANCILLARY	MG	MG	800	1	INTRAVENOUS	NA	NA	OTHER	NA	9600	NA
160	644571e9-b8e6-42f3-a2e4-33bad0fac661	TCGA.DC.4745	TCGA-DC-4745-D16798	abf58812-4c12-4734-ba99-80b3e107572f	2011-9-26	OXALIPLATIN	NA	CHEMOTHERAPY	62	FALSE	132	NA	NA	NA	NA	6	NA	MG	MG	170	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1020	NA
161	33e91116-8844-4861-843d-784c70b4a6fc	TCGA.DC.6154	TCGA-DC-6154-D17886	ae7103e5-b431-4be0-b041-09485384352a	2011-10-27	FLUOROURACIL	NA	CHEMOTHERAPY	91	FALSE	242	NA	NA	NA	NA	12	NA	NA	NA	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
162	33e91116-8844-4861-843d-784c70b4a6fc	TCGA.DC.6154	TCGA-DC-6154-D17883	1535646c-5346-457e-8157-8083e674308f	2011-10-27	FLUOROURACIL	NA	CHEMOTHERAPY	91	FALSE	242	NA	NA	NA	NA	12	NA	NA	NA	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
163	33e91116-8844-4861-843d-784c70b4a6fc	TCGA.DC.6154	TCGA-DC-6154-D17888	31ab0762-6f93-45f0-910b-0cc012bfbde4	2011-10-27	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	91	FALSE	242	NA	NA	NA	NA	12	ANCILLARY	NA	NA	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
164	33e91116-8844-4861-843d-784c70b4a6fc	TCGA.DC.6154	TCGA-DC-6154-D17889	ca705d57-a0eb-4310-8628-44af85e60bb9	2011-10-27	OXALIPLATIN	NA	CHEMOTHERAPY	91	FALSE	242	NA	NA	NA	NA	12	NA	NA	NA	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
165	eb75ca70-e60f-453f-820c-485390abad88	TCGA.DC.6155	TCGA-DC-6155-D15163	c6d39c6c-9b36-4771-9d2b-f7fd8791e5f4	2011-8-12	OXALIPLATIN	NA	CHEMOTHERAPY	57	FALSE	71	NA	NA	NA	NA	2	NA	MG	MG	130	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	260	NA
166	eb75ca70-e60f-453f-820c-485390abad88	TCGA.DC.6155	TCGA-DC-6155-D15164	0b815912-6451-40de-8bdf-676366ba19f1	2011-8-12	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	57	FALSE	239	NA	NA	NA	NA	11	ANCILLARY AGENT	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	5970	NA
167	eb75ca70-e60f-453f-820c-485390abad88	TCGA.DC.6155	TCGA-DC-6155-D15166	f7f4fe18-913d-4ce0-82a3-d4dc4d4b8759	2011-8-12	FLUOROURACIL	NA	CHEMOTHERAPY	57	FALSE	239	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	7600	NA
168	eb75ca70-e60f-453f-820c-485390abad88	TCGA.DC.6155	TCGA-DC-6155-D15168	2280d088-6312-4936-90a6-1076aecf0b11	2011-8-12	FLUOROURACIL	NA	CHEMOTHERAPY	57	FALSE	239	NA	NA	NA	NA	12	NA	MG	MG	1900	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	22800	NA
169	261925e3-96e4-440c-8e95-c003d44ab2f2	TCGA.DC.6156	TCGA-DC-6156-D15196	60a99194-92a3-4737-a849-330f061aa523	2011-8-15	OXALIPLATIN	NA	CHEMOTHERAPY	87	FALSE	269	NA	NA	NA	NA	12	NA	MG	MG	170	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	1830	NA
170	261925e3-96e4-440c-8e95-c003d44ab2f2	TCGA.DC.6156	TCGA-DC-6156-D15198	c3baaf92-b499-4f7a-9431-70b545c0e8d3	2011-8-15	FLUOROURACIL	NA	CHEMOTHERAPY	92	FALSE	334	NA	NA	NA	NA	17	NA	MG	MG	800	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	13600	NA
171	261925e3-96e4-440c-8e95-c003d44ab2f2	TCGA.DC.6156	TCGA-DC-6156-D15197	f501c115-db91-4cde-acb1-35d17cf23bed	2011-8-15	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	92	FALSE	334	NA	NA	NA	NA	17	ANCILLARY AGENT	MG	MG	210	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	3570	NA
172	261925e3-96e4-440c-8e95-c003d44ab2f2	TCGA.DC.6156	TCGA-DC-6156-D15199	609c5cb0-e725-45d6-991d-6064fdca9e45	2011-8-15	FLUOROURACIL	NA	CHEMOTHERAPY	92	FALSE	334	NA	NA	NA	NA	17	NA	MG	MG	2400	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	35500	NA
173	261925e3-96e4-440c-8e95-c003d44ab2f2	TCGA.DC.6156	TCGA-DC-6156-D21979	d409689c-b0f7-406a-bb0d-f9f1dc4b774f	2012-2-22	IRINOTECAN HCL	NA	CHEMOTHERAPY	365	TRUE	NA	NA	NA	NA	NA	8	NA	MG	MG	380	2	INTRAVENOUS	NA	NA	PALLIATIVE	NA	2800	NA
174	261925e3-96e4-440c-8e95-c003d44ab2f2	TCGA.DC.6156	TCGA-DC-6156-D21980	54129ecf-0125-45a8-8506-eb8248500ae8	2012-2-22	BEVACIZUMAB	NA	IMMUNOTHERAPY	395	TRUE	NA	NA	NA	NA	NA	6	NA	MG	MG	480	2	INTRAVENOUS	NA	NA	PALLIATIVE	NA	2880	NA
175	261925e3-96e4-440c-8e95-c003d44ab2f2	TCGA.DC.6156	TCGA-DC-6156-D29374	f4c74905-0f74-43ef-993d-bf84e70f61c1	2012-3-16	FLUOROURACIL	NA	CHEMOTHERAPY	365	TRUE	NA	NA	NA	NA	NA	8	NA	MG	MG	320	2	INTRAVENOUS	NA	NA	PALLIATIVE	NA	2368	NA
176	261925e3-96e4-440c-8e95-c003d44ab2f2	TCGA.DC.6156	TCGA-DC-6156-D29373	7924ad55-eb1c-47f3-a2b5-aefe07edff8d	2012-3-16	FLUOROURACIL	NA	CHEMOTHERAPY	365	TRUE	NA	NA	NA	NA	NA	8	NA	MG	MG	800	2	INTRAVENOUS	NA	NA	PALLIATIVE	NA	5920	NA
177	261925e3-96e4-440c-8e95-c003d44ab2f2	TCGA.DC.6156	TCGA-DC-6156-D29375	e8158296-a375-4c50-a27d-a7021b3a07d3	2012-3-16	LEUCOVORIN	NA	CHEMOTHERAPY	365	TRUE	NA	NA	NA	NA	NA	8	NA	MG	MG	100	2	INTRAVENOUS	NA	NA	PALLIATIVE	NA	740	NA
178	261925e3-96e4-440c-8e95-c003d44ab2f2	TCGA.DC.6156	TCGA-DC-6156-D44758	45C103CA-FAFA-4BE8-96BB-786E15D2D8CA	2013-6-26	BEVACIZUMAB	NA	CHEMOTHERAPY	395	FALSE	761	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
179	3e97286f-8aa8-4b6a-b339-d7a8e30f60c2	TCGA.DC.6681	TCGA-DC-6681-D17001	0389e5fe-ae72-4684-8857-a1786571f0fc	2011-9-29	FLUOROURACIL	NA	CHEMOTHERAPY	38	FALSE	136	NA	NA	NA	NA	8	NA	MG	MG	600	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	3920	NA
180	3e97286f-8aa8-4b6a-b339-d7a8e30f60c2	TCGA.DC.6681	TCGA-DC-6681-D17003	70773b35-24f4-40be-8d08-4e29f9b40993	2011-9-29	FLUOROURACIL	NA	CHEMOTHERAPY	38	FALSE	136	NA	NA	NA	NA	8	NA	MG	MG	1900	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	15200	NA
181	3e97286f-8aa8-4b6a-b339-d7a8e30f60c2	TCGA.DC.6681	TCGA-DC-6681-D17004	db7f6761-c134-48ba-b2f3-df57a979b4b1	2011-9-29	LEUCOVORIN CALCIUM	NA	OTHER, SPECIFY IN NOTES	38	FALSE	136	NA	NA	NA	NA	8	ANCILLARY	MG	MG	160	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1280	NA
182	3e97286f-8aa8-4b6a-b339-d7a8e30f60c2	TCGA.DC.6681	TCGA-DC-6681-D17005	f49b8f63-3f14-47e6-ac92-e3fe637e5299	2011-9-29	OXALIPLATIN	NA	CHEMOTHERAPY	38	FALSE	136	NA	NA	NA	NA	8	NA	MG	MG	110	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	850	NA
183	16a9e1c5-85c2-4930-a16c-af59114bac9a	TCGA.DC.6683	TCGA-DC-6683-D16998	102d8593-ffff-4a1e-8f0d-0d8e1dac97af	2012-4-18	OXALIPLATIN	NA	CHEMOTHERAPY	50	FALSE	214	NA	NA	NA	NA	12	NA	MG	MG	170	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1980	NA
184	16a9e1c5-85c2-4930-a16c-af59114bac9a	TCGA.DC.6683	TCGA-DC-6683-D16997	7b26e472-0f10-4ca1-9bb1-4dbd2a4852e9	2012-4-18	FLUOROURACIL	NA	CHEMOTHERAPY	50	FALSE	214	NA	NA	NA	NA	12	NA	MG	MG	2400	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	28800	NA
185	16a9e1c5-85c2-4930-a16c-af59114bac9a	TCGA.DC.6683	TCGA-DC-6683-D16996	c35d6f62-4fe4-460c-9ca1-eef4461e775d	2012-4-18	FLUOROURACIL	NA	CHEMOTHERAPY	50	FALSE	214	NA	NA	NA	NA	12	NA	MG	MG	800	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9600	NA
186	16a9e1c5-85c2-4930-a16c-af59114bac9a	TCGA.DC.6683	TCGA-DC-6683-D17000	d212da89-e3a1-4588-ab55-5f0513443f06	2012-4-18	LEUCOVORIN CALCIUM	NA	OTHER, SPECIFY IN NOTES	50	FALSE	214	NA	NA	NA	NA	12	ANCILLARY	MG	MG	800	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9600	NA
187	9df9af6b-00b0-47af-aac7-b52dac399ba5	TCGA.DY.A0XA	TCGA-DY-A0XA-D30448	3A895248-930E-46DE-99A6-2D6B7732C640	2012-4-10	MAYO 425-20	NA	CHEMOTHERAPY	47	FALSE	239	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
188	205f30ff-fb10-44a8-a1c6-c538de100db5	TCGA.DY.A1DC	TCGA-DY-A1DC-D30402	1DD51FDD-A9D3-4ECD-B3DF-F74DABB7F28D	2012-4-10	CAPECITABINE -XELODA	NA	CHEMOTHERAPY	771	FALSE	828	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
189	5555fbdd-962f-4d79-b36c-ae3c3cc4aff4	TCGA.DY.A1DE	TCGA-DY-A1DE-D30446	D369621F-ABAD-4DC9-B8ED-BAC84CF0BFB5	2012-4-10	MAYO 425-20	NA	CHEMOTHERAPY	46	FALSE	78	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
190	5555fbdd-962f-4d79-b36c-ae3c3cc4aff4	TCGA.DY.A1DE	TCGA-DY-A1DE-D30447	2B357047-E9A9-473A-9D6C-0DFD7D0DE8C8	2012-4-10	MAYO 425-20	NA	CHEMOTHERAPY	291	FALSE	379	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
191	d8bfcc67-f5c3-42cd-9fc4-bd483f896da1	TCGA.EI.6508	TCGA-EI-6508-D28936	a4922b17-c151-4bac-bd9d-a607e43949e8	2012-3-2	OXALIPLATINUM + 5-FU	NA	CHEMOTHERAPY	76	FALSE	258	NA	NA	NA	NA	12	NA	MG/M2/DAY	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
192	652e503a-1be8-445b-96d6-ff114f911e76	TCGA.EI.6509	TCGA-EI-6509-D28629	04e8bf95-c20c-4276-a4ca-0acf83597ea1	2012-2-27	FOLFOX	NA	CHEMOTHERAPY	395	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
193	d004a083-6dc6-4db6-96d0-88a8ca3b1b93	TCGA.EI.6511	TCGA-EI-6511-D28932	CA39B724-0291-4EB0-87A1-D85C280C3964	2012-3-2	OXALIPLATINUM+5-FU	NA	CHEMOTHERAPY	161	FALSE	182	NA	NA	NA	NA	3	NA	MG/M2/DAY	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
194	25b43e40-e1f9-42a0-8052-5138f381eed9	TCGA.EI.6512	TCGA-EI-6512-D28635	b21dc457-7653-4411-931f-6d024c1c33c1	2012-2-27	FOLFOX	NA	CHEMOTHERAPY	20	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
195	40974ab3-e532-4d6e-9c98-ee640f3976d6	TCGA.EI.6514	TCGA-EI-6514-D28631	139796C1-BFC0-4707-9CF2-52A9843422B6	2012-2-27	5-FU + LEULOV	NA	CHEMOTHERAPY	27	FALSE	88	NA	NA	NA	NA	NA	NA	MG	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
196	3aecf83e-c614-4ffa-8c82-1b5dadf6509e	TCGA.EI.6881	TCGA-EI-6881-D29850	b66c7bf1-c626-40ca-b707-a3848b2bdd0b	2012-3-30	5 FLUOROURACIL+LEUCOVORIN	NA	CHEMOTHERAPY	42	FALSE	250	NA	NA	NA	NA	6	NA	MG/M2	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
197	468c2ecb-a21f-49a7-91f3-63d3ef266cf8	TCGA.EI.6883	TCGA-EI-6883-D29852	f1e06e96-ffc3-4cf9-962b-2e718c64a40e	2012-3-30	5FLUOROURACIL+LEUCOVORIN	NA	CHEMOTHERAPY	55	FALSE	111	NA	NA	NA	NA	3	NA	MG/M2	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
198	b2b125c7-8993-4424-b390-048ccccc9d08	TCGA.EI.6884	TCGA-EI-6884-D29853	36a71370-2d4f-45ac-8144-14a8731a5ce6	2012-3-30	5 FLUOROURACILUM+LEUCOVORIN	NA	CHEMOTHERAPY	52	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/KG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
199	3165bf70-df19-4043-bcfc-9ae92197ef72	TCGA.EI.6885	TCGA-EI-6885-D29907	b055a1f4-d417-4577-9543-dac2a5baa90d	2012-3-30	OXALIPLATINUM+5 FLUOROURACILUM	NA	CHEMOTHERAPY	69	FALSE	308	NA	NA	NA	NA	12	NA	MG/M2	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
200	0cb21fb0-520f-4105-99ec-697a335115b5	TCGA.EI.6917	TCGA-EI-6917-D29855	4e8e5e86-a3d0-4b3d-b936-bc4046da5b55	2012-3-30	5FLUOROURACIL+OXACIPLATINA+L-FOLINIAN DISCIDO	NA	CHEMOTHERAPY	100	FALSE	145	NA	NA	NA	NA	NA	NA	MG/M2	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
201	2b1783da-9ede-4590-b96a-6b0eabc8777f	TCGA.EI.7002	TCGA-EI-7002-D29904	cfb19b7d-cb95-4630-a70b-ccae74ce829b	2012-3-30	IRINOTECAN+5-FLUOROURACILIM	NA	CHEMOTHERAPY	67	FALSE	224	NA	NA	NA	NA	12	NA	MG/M2	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
202	b2db7f47-540f-4bd3-81bb-d686b0225201	TCGA.EI.7004	TCGA-EI-7004-D29858	f1a23525-1b5a-4f36-93f3-2c78da97de62	2012-3-30	XELODA	NA	CHEMOTHERAPY	41	FALSE	188	NA	NA	NA	NA	7	NA	MG/M2	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
203	85947797-54b8-44fb-910b-5cd689542994	TCGA.F5.6571	TCGA-F5-6571-D29834	857CE230-D7C1-4EC3-A8E3-327337A6A5CD	2012-3-29	CAPECITABINE	NA	CHEMOTHERAPY	226	FALSE	350	NA	NA	NA	NA	6	NA	G/DAY	G/DAY	4	NA	ORAL	NA	NA	RECURRENCE	NA	336	NA
204	85947797-54b8-44fb-910b-5cd689542994	TCGA.F5.6571	TCGA-F5-6571-D53525	2B9D27E5-E361-4657-8DA6-21B9D8454DFD	2013-12-12	MITOMYCIN	NA	CHEMOTHERAPY	770	FALSE	813	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
205	85947797-54b8-44fb-910b-5cd689542994	TCGA.F5.6571	TCGA-F5-6571-D53527	2F82A9D7-83B1-4A8F-9EC8-D81BDCBF24B4	2013-12-12	5-FLUOROURACIL	NA	CHEMOTHERAPY	847	FALSE	952	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
206	85947797-54b8-44fb-910b-5cd689542994	TCGA.F5.6571	TCGA-F5-6571-D53530	08406C00-17CA-42E1-BB5F-919DD9BE7FD8	2013-12-12	LEUCOVORIN	NA	ANCILLARY	847	FALSE	952	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
207	85947797-54b8-44fb-910b-5cd689542994	TCGA.F5.6571	TCGA-F5-6571-D53531	E3940B66-3CF4-4484-A360-2A1E70F345EB	2013-12-12	OXALIPLATIN	NA	CHEMOTHERAPY	847	FALSE	952	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
208	85947797-54b8-44fb-910b-5cd689542994	TCGA.F5.6571	TCGA-F5-6571-D65905	AF8F3EF6-1533-41EA-9E07-49767EF773FB	2014-10-1	IRINOTECAN	NA	CHEMOTHERAPY	1065	FALSE	1157	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
209	85947797-54b8-44fb-910b-5cd689542994	TCGA.F5.6571	TCGA-F5-6571-D65907	752ADA80-5EDC-4F56-AEF4-F64C81591C01	2014-10-1	LEUCOVORIN	NA	ANCILLARY	1065	FALSE	1157	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
210	85947797-54b8-44fb-910b-5cd689542994	TCGA.F5.6571	TCGA-F5-6571-D65909	EB1AB997-77FB-4F19-A8CE-2B4F475F4548	2014-10-1	5-FLUOROURACIL	NA	CHEMOTHERAPY	1065	FALSE	1157	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
211	85947797-54b8-44fb-910b-5cd689542994	TCGA.F5.6571	TCGA-F5-6571-D65922	BFAF1A47-D8B9-4307-AB33-423277F0B8F8	2014-10-1	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	1065	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
212	85947797-54b8-44fb-910b-5cd689542994	TCGA.F5.6571	TCGA-F5-6571-D65923	55F67205-87D7-49DF-85D4-77DBA50B9A0A	2014-10-1	OXALIPLATIN	NA	CHEMOTHERAPY	1255	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
213	85947797-54b8-44fb-910b-5cd689542994	TCGA.F5.6571	TCGA-F5-6571-D65924	82FA8F68-90F5-42E8-8ABF-5A8C488D0F1E	2014-10-1	GEMCITABINE	NA	CHEMOTHERAPY	1255	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
214	f1ce4b5f-55d0-4989-a5f3-6b6e591538b2	TCGA.F5.6702	TCGA-F5-6702-D46350	AE38DEA3-6C5A-423C-B49F-86D4DCE40ED9	2013-8-6	5-FLUOROURACIL	NA	CHEMOTHERAPY	370	FALSE	641	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
215	f1ce4b5f-55d0-4989-a5f3-6b6e591538b2	TCGA.F5.6702	TCGA-F5-6702-D46351	4A439625-FA84-45EC-817B-67C23AFE1E37	2013-8-6	POLYPLATILLEN	NA	CHEMOTHERAPY	370	FALSE	641	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
216	f1ce4b5f-55d0-4989-a5f3-6b6e591538b2	TCGA.F5.6702	TCGA-F5-6702-D46352	A119CEAA-1B12-4770-B8B6-D4D1D7A38F0F	2013-8-6	OXALIPLATIN	NA	CHEMOTHERAPY	340	FALSE	551	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
217	72e640f2-869f-4aef-8ebe-b127f3e7048a	TCGA.F5.6863	TCGA-F5-6863-D35412	52352390-D906-4CD9-A1EF-85A68856259C	2012-9-26	ETOPOSIDE	NA	CHEMOTHERAPY	196	FALSE	251	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
218	72e640f2-869f-4aef-8ebe-b127f3e7048a	TCGA.F5.6863	TCGA-F5-6863-D35413	C49E0FEE-4847-4946-83B7-457EE6C96D86	2012-9-26	LEUCOVORIN	NA	CHEMOTHERAPY	196	FALSE	251	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
219	72e640f2-869f-4aef-8ebe-b127f3e7048a	TCGA.F5.6863	TCGA-F5-6863-D35414	A8C20AB5-CB1C-4F37-B128-2926781CD0FF	2012-9-26	5-FLUOROURACIL	NA	CHEMOTHERAPY	196	FALSE	251	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
220	72e640f2-869f-4aef-8ebe-b127f3e7048a	TCGA.F5.6863	TCGA-F5-6863-D35415	DDBA0B34-8873-49AE-865D-C33764098442	2012-9-26	XELODA	NA	CHEMOTHERAPY	261	FALSE	289	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
221	3546a93b-b279-4615-9d5f-5baa787e487e	TCGA.F5.6864	TCGA-F5-6864-D33874	A7C58EE8-6D8E-465B-879A-863167346D8A	2012-7-23	5-FLUOROURACIL	NA	CHEMOTHERAPY	17	FALSE	191	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
222	3546a93b-b279-4615-9d5f-5baa787e487e	TCGA.F5.6864	TCGA-F5-6864-D33875	591BBBE2-4B58-48F4-B353-932C79B86C0F	2012-7-23	LEUCOVORIN	NA	ANCILLARY	17	FALSE	191	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
223	ff427104-0727-483c-8513-243dec80db9d	TCGA.G5.6233	TCGA-G5-6233-D21974	5646f05f-fd36-42e5-8ff3-7e36ff7ad118	2012-2-6	FLUOROURACIL	NA	CHEMOTHERAPY	117	FALSE	270	NA	NA	NA	NA	9	NA	NA	NA	NA	1	NA	NA	NA	PROGRESSION	NA	NA	NA
224	ff427104-0727-483c-8513-243dec80db9d	TCGA.G5.6233	TCGA-G5-6233-D21976	de57c88f-e829-4be0-8365-eee4b531dd1d	2012-2-6	LEUCOVORIN	NA	CHEMOTHERAPY	117	FALSE	270	NA	NA	NA	NA	9	NA	NA	NA	NA	1	NA	NA	NA	PROGRESSION	NA	NA	NA
225	ff427104-0727-483c-8513-243dec80db9d	TCGA.G5.6233	TCGA-G5-6233-D21971	8151e8a5-d1e3-4f9f-b00c-c87ca2e13f6b	2012-2-6	OXALIPLATIN	NA	CHEMOTHERAPY	117	FALSE	270	NA	NA	NA	NA	9	NA	NA	NA	NA	1	NA	NA	NA	PROGRESSION	NA	NA	NA
226	c2ea7b58-cabd-407e-98ce-6cbf9e4d93e1	TCGA.G5.6235	TCGA-G5-6235-D21955	05fe541d-4408-48c0-88e2-865b333fb9e5	2012-2-7	LEUCOVORIN	NA	CHEMOTHERAPY	33	FALSE	187	NA	NA	NA	NA	12	NA	MG	MG	720	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	8848	NA
227	c2ea7b58-cabd-407e-98ce-6cbf9e4d93e1	TCGA.G5.6235	TCGA-G5-6235-D21956	b0ca40c0-6174-4371-bf39-12d2ff45d079	2012-2-7	OXALIPLATIN	NA	CHEMOTHERAPY	33	FALSE	187	NA	NA	NA	NA	12	NA	MG	MG	150	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1880	NA
228	c2ea7b58-cabd-407e-98ce-6cbf9e4d93e1	TCGA.G5.6235	TCGA-G5-6235-D21953	b59a484b-cd0a-4482-ab1d-4310539df12e	2012-2-7	FLUOROURACIL	NA	CHEMOTHERAPY	89	FALSE	187	NA	NA	NA	NA	8	NA	MG	MG	740	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	5968	NA
229	0a2cb2f9-972c-450c-8b7a-115a4cb93658	TCGA.G5.6641	TCGA-G5-6641-D21865	d81354b9-0c34-4fcc-8b3f-e3f107f69534	2012-2-7	OXALIPLATIN	NA	CHEMOTHERAPY	100	FALSE	212	NA	NA	NA	NA	9	NA	MG	MG	210	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1862	NA
230	0a2cb2f9-972c-450c-8b7a-115a4cb93658	TCGA.G5.6641	TCGA-G5-6641-D21867	5bf0d06d-1ace-46e0-a4ca-0994b79721e7	2012-2-7	FLUOROURACIL	NA	CHEMOTHERAPY	100	FALSE	254	NA	NA	NA	NA	12	NA	MG	MG	980	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	11632	NA
231	0a2cb2f9-972c-450c-8b7a-115a4cb93658	TCGA.G5.6641	TCGA-G5-6641-D21868	9a002138-e55e-40ed-bc8d-9878e0bdcd74	2012-2-7	LEUCOVORIN	NA	CHEMOTHERAPY	100	FALSE	254	NA	NA	NA	NA	12	NA	MG	MG	980	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	11632	NA
